Alan Nisbet is an expert in the field of Urology. He studied medicine at University of Kansas School of Medicine. Alan Nisbet is also a published MD. He has 6 publication published. The most recent publication is: A Phase II Clinical Trial of Neoadjuvant Ketoconazole and Docetaxel Chemotherapy Before Radical Prostatectomy in High Risk Patients. Alan A. Nisbet is registered with Medicare.
NPI NUMBER | 1700920964 | |
NPPES Provider LastName | NISBET | |
NPPES Provider FirstName | ALAN | |
NPPES Provider ZIPCode | 784112547 | |
NPPES Provider State | TX | |
Specialty Description | Urology | |
Total Claim Count | 1871.0 | |
Distinct Opioid Count | 2.0 | |
Opioid Claim Count | 75.0 | |
Percent Opioid Claims | 4.01 |
National Provider Identifier [NPI] | 1700920964 |
Last Name Of The Provider | NISBET |
First Name Of The Provider | ALAN |
View All |
![]() |
Dr. Jason D. Fisher, DO |
![]() |
Dr. Frederick J. McCutchon, MD |